AstraZeneca
AZN
#47
Rank
โ‚น25.119 T
Marketcap
โ‚น8,101
Share price
0.17%
Change (1 day)
44.69%
Change (1 year)

Revenue for AstraZeneca (AZN)

Revenue in 2025 (TTM): โ‚น5.027 Trillion

According to AstraZeneca's latest financial reports the company's current revenue (TTM ) is โ‚น5.221 Trillion. In 2024 the company made a revenue of โ‚น4.638 Trillion an increase over the revenue in the year 2023 that were of โ‚น3.813 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AstraZeneca from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น5.027 T8.38%
2024 โ‚น4.638 T21.63%
2023 โ‚น3.813 T3.92%
2022 โ‚น3.669 T31.78%
2021 โ‚น2.784 T43.07%
2020 โ‚น1.946 T11.95%
2019 โ‚น1.738 T12.58%
2018 โ‚น1.544 T7.68%
2017 โ‚น1.434 T-8.23%
2016 โ‚น1.563 T-4.8%
2015 โ‚น1.641 T-2.29%
2014 โ‚น1.680 T5.79%
2013 โ‚น1.588 T3.71%
2012 โ‚น1.531 T-13.81%
2011 โ‚น1.776 T19.2%
2010 โ‚น1.490 T-2.06%
2009 โ‚น1.522 T0.21%
2008 โ‚น1.518 T30.93%
2007 โ‚น1.160 T-1.07%
2006 โ‚น1.172 T8.8%
2005 โ‚น1.077 T16.15%
2004 โ‚น927.91 B8.12%
2003 โ‚น858.19 B1.42%
2002 โ‚น846.19 B-25.48%
2001 โ‚น1.135 T34.3%
2000 โ‚น845.50 B5.5%
1999 โ‚น801.46 B91.84%
1998 โ‚น417.78 B18.71%
1997 โ‚น351.94 B-14.33%
1996 โ‚น410.82 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Bristol-Myers Squibb
BMY
โ‚น4.315 T-17.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.640 T 8.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.770 T 10.51%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น3.804 T-27.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
โ‚น4.269 T-18.24%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
โ‚น5.338 T 2.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 T 58.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น3.938 T-24.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น904.28 B-82.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.064 T-3.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland